Long term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)
Huddart, R.A., Cafferty, F., White, J., Shamash, J., Hennig, I.M., Cullen, M., Stenning, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Substance-P receptors in human primary neoplasms: tumoral and vascular localization
Hennig, I M, Laissue, J A, Horisberger, U, Reubi, J C
Published in International journal of cancer (09.06.1995)
Published in International journal of cancer (09.06.1995)
Get more information
Journal Article
Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo
Harvey, T J, Hennig, I M, Shnyder, S D, Cooper, P A, Ingram, N, Hall, G D, Selby, P J, Chester, J D
Published in Cancer gene therapy (01.11.2011)
Published in Cancer gene therapy (01.11.2011)
Get full text
Journal Article
915PLong term follow-up of the MRC TE23 randomized phase II trial of intensive induction chemotherapy (CBOP/BEP) in poor prognosis germ cell tumours (GCT) (CRUK/05/014; ISRCTN53643604)
Huddart, R A, Cafferty, F, White, J, Shamash, J, Hennig, I M, Cullen, M, Stenning, S
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article